Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-01-04 @ 7:44 AM
Study NCT ID:
NCT01499160
Status:
TERMINATED
Last Update Posted:
2022-02-11
First Post:
2011-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
Sponsor:
University of Maryland, Baltimore
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HP-00040802; GCC 0901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None